BBI Detection specialises in the development and supply of innovative technologies for the detection and decontamination of biological threats, explosives and narcotics. We are committed to creating and supplying innovative technology that will meet identified capability gaps across the CBRNe field to support military, first responder and security markets.
With secure facilities in the US and UK, and over 25 years’ experience in the development of assays, we are ideally placed to serve the needs of military and first responder markets worldwide.
Our Integrated Multiplex Assay and Sampling System – IMASS™ platform solves the problem of sampling and identification of biothreats and explosives in ‘white powder’ incidents, due to its patented ergonomic design. The device was originally conceived by a cross-functional team of engineers and scientists at DSTL (the UK’s Defence Science and Technology Laboratories), and BBI Detection have since obtained a licence from the UK Secretary of State for Defence to develop and manufacture the IMASS™ device.
BBI Detection also distribute a unique product portfolio of simple to use, rapid and low cost solutions for the presumptive identification of explosives and narcotics and a simple, efficient dry decontamination solution.